FDA Inspection 774760 — Institute For Reproductive Health
The FDA completed an inspection of Institute For Reproductive Health on Mar 29, 2012 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 29, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cincinnati, OH (United States)